Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 268


Transcriptome-based molecular subtyping of non-small cell lung cancer may predict response to immune checkpoint inhibitors.

Jang HJ, Lee HS, Ramos D, Park IK, Kang CH, Burt BM, Kim YT.

J Thorac Cardiovasc Surg. 2019 Nov 11. pii: S0022-5223(19)32515-2. doi: 10.1016/j.jtcvs.2019.10.123. [Epub ahead of print]


Predictors of benefits from frontline chemoimmunotherapy in stage IV non-small-cell lung cancer: a meta-analysis.

El-Osta HE, Mott FE, Burt BM, Wang DY, Sabichi AL.

Oncoimmunology. 2019 Sep 20;8(12):e1665974. doi: 10.1080/2162402X.2019.1665974. eCollection 2019.


The prospective database on thymic epithelial tumours from the European Continent.

Hamaji M, Miyahara S, Lee HS, Burt BM.

J Thorac Dis. 2019 Sep;11(Suppl 15):S1925-S1926. doi: 10.21037/jtd.2019.08.113. No abstract available.


Radiologic Considerations and Standardization of Malignant Pleural Mesothelioma Imaging Within Clinical Trials: Consensus Statement from the NCI Thoracic Malignancy Steering Committee - International Association for the Study of Lung Cancer - Mesothelioma Applied Research Foundation Clinical Trials Planning Meeting.

Gill RR, Tsao AS, Kindler HL, Richards WG, Armato SG 3rd, Francis RJ, Gomez DR, Dahlberg S, Rimner A, Simone CB 2nd, de Perrot M, Blumenthal G, Adjei AA, Bueno R, Harpole DH Jr, Hesdorffer M, Hirsch FR, Pass HI, Yorke E, Rosenzweig K, Burt B, Fennell DA, Lindwasser W, Malik S, Peikert T, Mansfield AS, Salgia R, Yang H, Rusch VW, Nowak AK.

J Thorac Oncol. 2019 Oct;14(10):1718-1731. doi: 10.1016/j.jtho.2019.08.012. Epub 2019 Aug 27.


Commentary: Usurping the king: A step toward planning a biological checkmate on non-small cell lung carcinoma.

Groth SS, Ripley RT, Carrott P, Burt BM.

J Thorac Cardiovasc Surg. 2019 Sep;158(3):922-923. doi: 10.1016/j.jtcvs.2019.05.049. Epub 2019 May 30. No abstract available.


Necessity of the heart, for lung resection.

Salter KD, Burt BM.

J Thorac Dis. 2019 May;11(Suppl 9):S1132-S1134. doi: 10.21037/jtd.2019.04.72. No abstract available.


A Proposed System Toward Standardizing Surgical-Based Treatments for Malignant Pleural Mesothelioma, From the Joint National Cancer Institute-International Association for the Study of Lung Cancer-Mesothelioma Applied Research Foundation Taskforce.

Friedberg JS, Culligan MJ, Tsao AS, Rusch V, Sepesi B, Pass HI, Bueno R, Burt B, Sugarbaker DJ, de Perrot M, Adjei AA, Adusumilli PS, Hirsch FR, Malik SM, Harpole DJ Jr.

J Thorac Oncol. 2019 Aug;14(8):1343-1353. doi: 10.1016/j.jtho.2019.04.029. Epub 2019 May 25. Review.


A year at the forefront of general thoracic surgery.

Burt BM.

J Thorac Cardiovasc Surg. 2019 Jul;158(1):248-251. doi: 10.1016/j.jtcvs.2019.04.004. Epub 2019 Apr 12. No abstract available.


Commentary: Adjuvant intensity-modulated radiation therapy for malignant pleural mesothelioma: Suspension of intention.

Groth SS, Burt BM, Ripley RT.

J Thorac Cardiovasc Surg. 2019 Sep;158(3):932-933. doi: 10.1016/j.jtcvs.2019.03.023. Epub 2019 Mar 22. No abstract available.


The impact of insight on post-lobectomy complications.

Ibrahim K, Burt BM.

J Thorac Dis. 2019 Mar;11(Suppl 3):S289-S290. doi: 10.21037/jtd.2019.01.38. No abstract available.


Utilization of Minimally Invasive Thymectomy and Margin-Negative Resection for Early-Stage Thymoma.

Burt BM, Nguyen D, Groth SS, Palivela N, Ripley RT, Makris KI, Farjah F, Cornwell L, Massarweh NN.

Ann Thorac Surg. 2019 Aug;108(2):405-411. doi: 10.1016/j.athoracsur.2019.03.010. Epub 2019 Apr 3.


Commentary: Postoperative blood transplantation for non-small cell lung cancer.

Salter KD, Burt BM.

J Thorac Cardiovasc Surg. 2019 Jun;157(6):2480-2481. doi: 10.1016/j.jtcvs.2019.01.049. Epub 2019 Jan 25. No abstract available.


Prognostic value of neoadjuvant treatment response in locally advanced esophageal adenocarcinoma.

Groth SS, Burt BM, Farjah F, Smaglo BG, Sada YH, Sugarbaker DJ, Massarweh NN.

J Thorac Cardiovasc Surg. 2019 Apr;157(4):1682-1693.e1. doi: 10.1016/j.jtcvs.2018.11.131. Epub 2018 Dec 15.


The elusive ground glass opacity, revealed.

Korb ML, Burt BM.

J Thorac Dis. 2018 Nov;10(Suppl 33):S3828-S3830. doi: 10.21037/jtd.2018.09.41. No abstract available.


Stage the Mediastinum.

Burt BM.

J Thorac Cardiovasc Surg. 2018 Nov 24. pii: S0022-5223(18)33140-4. doi: 10.1016/j.jtcvs.2018.11.037. [Epub ahead of print] No abstract available.


A thinner peel to peel: Pleural thickness is prognostic in mesothelioma.

Groth SS, Ripley RT, Burt BM.

J Thorac Cardiovasc Surg. 2019 Jan;157(1):414-415. doi: 10.1016/j.jtcvs.2018.10.005. Epub 2018 Oct 12. No abstract available.


To slay a dragon: Timing of chemotherapy in resectable pleural mesothelioma.

Burt BM, Ripley RT, Groth SS.

J Thorac Cardiovasc Surg. 2019 Feb;157(2):767-768. doi: 10.1016/j.jtcvs.2018.10.110. Epub 2018 Nov 2. No abstract available.


Approach to a Posterior Cervicomediastinal Ganglioneuroma.

Lee F, Yu W, Loor G, Burt BM.

Ann Thorac Surg. 2019 May;107(5):e349-e351. doi: 10.1016/j.athoracsur.2018.08.092. Epub 2018 Oct 23.


Current and Future Management of Malignant Mesothelioma: A Consensus Report from the National Cancer Institute Thoracic Malignancy Steering Committee, International Association for the Study of Lung Cancer, and Mesothelioma Applied Research Foundation.

Tsao AS, Lindwasser OW, Adjei AA, Adusumilli PS, Beyers ML, Blumenthal GM, Bueno R, Burt BM, Carbone M, Dahlberg SE, de Perrot M, Fennell DA, Friedberg J, Gill RR, Gomez DR, Harpole DH Jr, Hassan R, Hesdorffer M, Hirsch FR, Hmeljak J, Kindler HL, Korn EL, Liu G, Mansfield AS, Nowak AK, Pass HI, Peikert T, Rimner A, Robinson BWS, Rosenzweig KE, Rusch VW, Salgia R, Sepesi B, Simone CB 2nd, Sridhara R, Szlosarek P, Taioli E, Tsao MS, Yang H, Zauderer MG, Malik SM.

J Thorac Oncol. 2018 Nov;13(11):1655-1667. doi: 10.1016/j.jtho.2018.08.2036. Epub 2018 Sep 25.


Povidone-iodine results in rapid killing of thymic epithelial tumour cells through cellular fixation†.

Lee HS, Jang HJ, Lo EM, Truong CY, Groth SS, Friedberg JS, Sugarbaker DJ, Burt BM.

Interact Cardiovasc Thorac Surg. 2019 Mar 1;28(3):353-359. doi: 10.1093/icvts/ivy248.


Standardizing the time-honored wedge resection.

Hamaji M, Miyahara S, Lee HS, Burt BM.

J Thorac Dis. 2018 Jul;10(Suppl 18):S2206-S2208. doi: 10.21037/jtd.2018.06.155. No abstract available.


Vismodegib and orbital excision for treating locally advanced basal cell carcinoma.

Hogarty DT, Dewhurst NG, Burt B.

Int Med Case Rep J. 2018 Jul 31;11:177-179. doi: 10.2147/IMCRJ.S168666. eCollection 2018.


Mutation Ensemble for Response to Programmed Cell Death 1 Inhibition in Thymic Carcinoma.

Lee HS, Truong CY, Burt BM.

J Thorac Oncol. 2018 Aug;13(8):e150-e152. doi: 10.1016/j.jtho.2018.03.027. No abstract available.


A Phase I Trial of Surgical Resection and Intraoperative Hyperthermic Cisplatin and Gemcitabine for Pleural Mesothelioma.

Burt BM, Richards WG, Lee HS, Bartel S, Dasilva MC, Gill RR, Jaklitsch MT, Johnson BE, Swanson SJ, Bueno R, Sugarbaker DJ.

J Thorac Oncol. 2018 Sep;13(9):1400-1409. doi: 10.1016/j.jtho.2018.04.032. Epub 2018 May 9.


Guidelines for stereotactic body radiation therapy treatment of lung cancer highlight important research questions: what is the next step?

Cornwell LD, Korb ML, Burt BM.

J Thorac Dis. 2018 Mar;10(3):1339-1342. doi: 10.21037/jtd.2018.03.36. No abstract available.


Giant Mediastinal Liposarcoma: A Rare Yet Distinct Clinical Entity.

Nguyen DC, Olatubosun O, Yu W, Loor G, Burt BM.

Ann Thorac Surg. 2018 Sep;106(3):e117-e119. doi: 10.1016/j.athoracsur.2018.03.018. Epub 2018 Apr 12.


IL17A Regulates Tumor Latency and Metastasis in Lung Adeno and Squamous SQ.2b and AD.1 Cancer.

You R, DeMayo FJ, Liu J, Cho SN, Burt BM, Creighton CJ, Casal RF, Lazarus DR, Lu W, Tung HY, Yuan X, Hill-McAlester A, Kim M, Perusich S, Cornwell L, Rosen D, Song LZ, Paust S, Diehl G, Corry D, Kheradmand F.

Cancer Immunol Res. 2018 Jun;6(6):645-657. doi: 10.1158/2326-6066.CIR-17-0554. Epub 2018 Apr 13.


Thoracic outlet syndrome for thoracic surgeons.

Burt BM.

J Thorac Cardiovasc Surg. 2018 Sep;156(3):1318-1323.e1. doi: 10.1016/j.jtcvs.2018.02.096. Epub 2018 Mar 13. No abstract available.


Comprehensive immunoproteogenomic analyses of malignant pleural mesothelioma.

Lee HS, Jang HJ, Choi JM, Zhang J, de Rosen VL, Wheeler TM, Lee JS, Tu T, Jindra PT, Kerman RH, Jung SY, Kheradmand F, Sugarbaker DJ, Burt BM.

JCI Insight. 2018 Apr 5;3(7). pii: 98575. doi: 10.1172/jci.insight.98575. eCollection 2018 Apr 5.


Therapeutic R2 resection for pleural mesothelioma.

Nguyen D, Sugarbaker DJ, Burt BM.

J Thorac Cardiovasc Surg. 2018 Jun;155(6):2734-2735. doi: 10.1016/j.jtcvs.2018.01.025. Epub 2018 Feb 1. No abstract available.


Matrix metalloproteinase 12 promotes tumor propagation in the lung.

Ella E, Harel Y, Abraham M, Wald H, Benny O, Karsch-Bluman A, Vincent D, Laurent D, Amir G, Izhar U, Shapira OM, Yoon D, Lee HS, Sugarbaker DJ, Burt B, Peled A, Wald O.

J Thorac Cardiovasc Surg. 2018 May;155(5):2164-2175.e1. doi: 10.1016/j.jtcvs.2017.11.110. Epub 2018 Feb 21. Erratum in: J Thorac Cardiovasc Surg. 2019 Sep;158(3):966.


The printed trachea.

Patel V, Burt BM.

J Thorac Dis. 2017 Oct;9(10):3672-3673. doi: 10.21037/jtd.2017.09.49. No abstract available.


The importance of R0.

Ibrahim K, Burt BM.

J Thorac Cardiovasc Surg. 2018 Jan;155(1):428-429. doi: 10.1016/j.jtcvs.2017.09.064. No abstract available.


Computed Tomography Features associated With the Eighth Edition TNM Stage Classification for Thymic Epithelial Tumors.

Padda SK, Terrone D, Tian L, Khuong A, Neal JW, Riess JW, Berry MF, Hoang CD, Burt BM, Leung AN, Schwartz EJ, Shrager JB, Wakelee HA.

J Thorac Imaging. 2018 May;33(3):176-183. doi: 10.1097/RTI.0000000000000310.


Paraneoplastic Syndromes and Thymic Malignancies: An Examination of the International Thymic Malignancy Interest Group Retrospective Database.

Padda SK, Yao X, Antonicelli A, Riess JW, Shang Y, Shrager JB, Korst R, Detterbeck F, Huang J, Burt BM, Wakelee HA, Badve SS.

J Thorac Oncol. 2018 Mar;13(3):436-446. doi: 10.1016/j.jtho.2017.11.118. Epub 2017 Nov 27.


Programmed death ligand 1-associated antitumor immunity in early-stage non-small cell lung cancer: Expression of major histocompatibility complex I as a prerequisite.

Burt BM.

J Thorac Cardiovasc Surg. 2018 Jan;155(1):393-394. doi: 10.1016/j.jtcvs.2017.08.061. Epub 2017 Sep 1. No abstract available.


Soluble Mesothelin-Related Peptides to Monitor Recurrence After Resection of Pleural Mesothelioma.

Burt BM, Lee HS, Lenge De Rosen V, Hamaji M, Groth SS, Wheeler TM, Sugarbaker DJ.

Ann Thorac Surg. 2017 Nov;104(5):1679-1687. doi: 10.1016/j.athoracsur.2017.06.042. Epub 2017 Sep 28.


Subspecialty certification in thoracic oncology: Toward your next diploma.

Groth SS, Burt BM.

J Thorac Cardiovasc Surg. 2017 Oct;154(4):1393-1394. doi: 10.1016/j.jtcvs.2017.08.001. Epub 2017 Aug 12. No abstract available.


Extending the survival advantage of ground glass.

Lee F, Burt BM.

J Thorac Dis. 2017 Jul;9(7):1828-1830. doi: 10.21037/jtd.2017.06.83. No abstract available.


Cancer Immunotherapy: Historical Perspective of a Clinical Revolution and Emerging Preclinical Animal Models.

Decker WK, da Silva RF, Sanabria MH, Angelo LS, Guimarães F, Burt BM, Kheradmand F, Paust S.

Front Immunol. 2017 Aug 2;8:829. doi: 10.3389/fimmu.2017.00829. eCollection 2017. Review.


Intraoperative adjuncts for malignant pleural mesothelioma.

Chan WH, Sugarbaker DJ, Burt BM.

Transl Lung Cancer Res. 2017 Jun;6(3):285-294. doi: 10.21037/tlcr.2017.05.04. Review.


Orbital floor fracture with entrapment: Imaging and clinical correlations in 45 cases.

Silverman N, Spindle J, Tang SX, Wu A, Hong BK, Shore JW, Wester S, Levin F, Connor M, Burt B, Nakra T, Shepler T, Hink E, El-Sawy T, Shinder R.

Orbit. 2017 Oct;36(5):331-336. doi: 10.1080/01676830.2017.1337180. Epub 2017 Jul 13.


Overall Survival Following Thoracoscopic vs Open Lobectomy for Early-stage Non-small Cell Lung Cancer: A Meta-analysis.

Hamaji M, Lee HS, Kawaguchi A, Burt BM.

Semin Thorac Cardiovasc Surg. 2017 Spring;29(1):104-112. doi: 10.1053/j.semtcvs.2017.01.009. Epub 2017 Feb 22. Review.


Incompletely resected non-small cell lung cancer: Do we know how to handle a positive margin?

Burt BM.

J Thorac Cardiovasc Surg. 2017 Aug;154(2):673-674. doi: 10.1016/j.jtcvs.2017.04.009. Epub 2017 Apr 12. No abstract available.


Alternative conduits for esophageal replacement.

Bakshi A, Sugarbaker DJ, Burt BM.

Ann Cardiothorac Surg. 2017 Mar;6(2):137-143. doi: 10.21037/acs.2017.03.07.


Genomic Analysis of Thymic Epithelial Tumors Identifies Novel Subtypes Associated with Distinct Clinical Features.

Lee HS, Jang HJ, Shah R, Yoon D, Hamaji M, Wald O, Lee JS, Sugarbaker DJ, Burt BM.

Clin Cancer Res. 2017 Aug 15;23(16):4855-4864. doi: 10.1158/1078-0432.CCR-17-0066. Epub 2017 Apr 11.


A Meta-Analysis of Postoperative Radiotherapy for Thymic Carcinoma.

Hamaji M, Shah RM, Ali SO, Bettenhausen A, Lee HS, Burt BM.

Ann Thorac Surg. 2017 May;103(5):1668-1675. doi: 10.1016/j.athoracsur.2016.12.042. Epub 2017 Mar 31. Review.


Clarity and clairvoyance: Review and prediction of management guidelines for early stage lung cancer.

Burt BM.

J Thorac Cardiovasc Surg. 2017 Jun;153(6):1563-1564. doi: 10.1016/j.jtcvs.2017.01.040. Epub 2017 Feb 8. No abstract available.


Thoracoscopic lobectomy for clinical N2 and N1 lung cancer: Innovation outpacing standard of care.

Burt BM.

J Thorac Cardiovasc Surg. 2017 Apr;153(4):977-978. doi: 10.1016/j.jtcvs.2016.12.022. Epub 2017 Jan 10. No abstract available.


Radiography nomography: Utility of a calculator in rational preoperative decision making for subsolid pulmonary nodules.

Burt BM.

J Thorac Cardiovasc Surg. 2017 Feb;153(2):460-461. doi: 10.1016/j.jtcvs.2016.10.047. Epub 2016 Nov 3. No abstract available.

Supplemental Content

Support Center